BROOKFIELD ASSET MGMT-A (BAM.CA) Fundamental Analysis & Valuation

TSX:BAM • CA1130041058

62.58 CAD
-1.98 (-3.07%)
Last: Mar 6, 2026, 07:00 PM

This BAM.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall BAM gets a fundamental rating of 6 out of 10. We evaluated BAM against 80 industry peers in the Capital Markets industry. BAM has only an average score on both its financial health and profitability. BAM is valued quite expensive, but it does show an excellent growth. With these ratings, BAM could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. BAM.CA Profitability Analysis

1.1 Basic Checks

  • In the past year BAM was profitable.
  • In the past year BAM had a positive cash flow from operations.
  • Each year in the past 5 years BAM has been profitable.
  • In multiple years BAM reported negative operating cash flow during the last 5 years.
BAM.CA Yearly Net Income VS EBIT VS OCF VS FCFBAM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 12.78%, BAM is in the better half of the industry, outperforming 77.50% of the companies in the same industry.
  • BAM's Return On Equity of 21.06% is amongst the best of the industry. BAM outperforms 87.50% of its industry peers.
  • BAM's Return On Invested Capital of 10.70% is amongst the best of the industry. BAM outperforms 81.25% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BAM is below the industry average of 10.69%.
  • The 3 year average ROIC (6.82%) for BAM is below the current ROIC(10.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.78%
ROE 21.06%
ROIC 10.7%
ROA(3y)13.66%
ROA(5y)9.77%
ROE(3y)20.83%
ROE(5y)16.44%
ROIC(3y)6.82%
ROIC(5y)5.8%
BAM.CA Yearly ROA, ROE, ROICBAM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 60.89%, BAM is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • BAM's Profit Margin has improved in the last couple of years.
  • BAM's Operating Margin of 52.67% is fine compared to the rest of the industry. BAM outperforms 77.50% of its industry peers.
  • In the last couple of years the Operating Margin of BAM has declined.
Industry RankSector Rank
OM 52.67%
PM (TTM) 60.89%
GM N/A
OM growth 3Y177.57%
OM growth 5Y-1.81%
PM growth 3Y0.15%
PM growth 5Y22.8%
GM growth 3YN/A
GM growth 5YN/A
BAM.CA Yearly Profit, Operating, Gross MarginsBAM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

6

2. BAM.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BAM has more shares outstanding
  • The number of shares outstanding for BAM has been increased compared to 5 years ago.
  • The debt/assets ratio for BAM is higher compared to a year ago.
BAM.CA Yearly Shares OutstandingBAM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
BAM.CA Yearly Total Debt VS Total AssetsBAM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • BAM has an Altman-Z score of 7.79. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
  • BAM has a better Altman-Z score (7.79) than 85.00% of its industry peers.
  • BAM has a debt to FCF ratio of 1.82. This is a very positive value and a sign of high solvency as it would only need 1.82 years to pay back of all of its debts.
  • BAM has a Debt to FCF ratio of 1.82. This is in the better half of the industry: BAM outperforms 77.50% of its industry peers.
  • BAM has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
  • BAM has a Debt to Equity ratio of 0.28. This is comparable to the rest of the industry: BAM outperforms 51.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.82
Altman-Z 7.79
ROIC/WACCN/A
WACCN/A
BAM.CA Yearly LT Debt VS Equity VS FCFBAM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.43 indicates that BAM should not have too much problems paying its short term obligations.
  • BAM has a Current ratio of 1.43. This is in the better half of the industry: BAM outperforms 62.50% of its industry peers.
  • A Quick Ratio of 1.43 indicates that BAM should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.43, BAM is in the better half of the industry, outperforming 63.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.43
BAM.CA Yearly Current Assets VS Current LiabilitesBAM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. BAM.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.24% over the past year.
  • Measured over the past years, BAM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
  • BAM shows a strong growth in Revenue. In the last year, the Revenue has grown by 883.61%.
  • The Revenue has been growing by 17.46% on average over the past years. This is quite good.
EPS 1Y (TTM)17.24%
EPS 3Y212.1%
EPS 5Y8.95%
EPS Q2Q%17.5%
Revenue 1Y (TTM)883.61%
Revenue growth 3Y406.83%
Revenue growth 5Y17.46%
Sales Q2Q%42.24%

3.2 Future

  • BAM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.22% yearly.
  • The Revenue is expected to grow by 13.18% on average over the next years. This is quite good.
EPS Next Y9.52%
EPS Next 2Y13.19%
EPS Next 3Y15.89%
EPS Next 5Y14.22%
Revenue Next Year15.52%
Revenue Next 2Y15.48%
Revenue Next 3Y13.51%
Revenue Next 5Y13.18%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BAM.CA Yearly Revenue VS EstimatesBAM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
BAM.CA Yearly EPS VS EstimatesBAM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

3

4. BAM.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 26.97, the valuation of BAM can be described as expensive.
  • 68.75% of the companies in the same industry are cheaper than BAM, based on the Price/Earnings ratio.
  • BAM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.29.
  • BAM is valuated rather expensively with a Price/Forward Earnings ratio of 24.67.
  • BAM's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, BAM is valued at the same level.
Industry RankSector Rank
PE 26.97
Fwd PE 24.67
BAM.CA Price Earnings VS Forward Price EarningsBAM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, BAM is valued a bit cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 48.92
EV/EBITDA N/A
BAM.CA Per share dataBAM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of BAM may justify a higher PE ratio.
  • BAM's earnings are expected to grow with 15.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.83
PEG (5Y)3.01
EPS Next 2Y13.19%
EPS Next 3Y15.89%

3

5. BAM.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.11%, BAM has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 3.09, BAM has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, BAM pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

  • BAM has been paying a dividend for over 5 years, so it has already some track record.
  • BAM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
BAM.CA Yearly Dividends per shareBAM.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • BAM pays out 107.77% of its income as dividend. This is not a sustainable payout ratio.
DP107.77%
EPS Next 2Y13.19%
EPS Next 3Y15.89%
BAM.CA Yearly Income VS Free CF VS DividendBAM.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B
BAM.CA Dividend Payout.BAM.CA Dividend Payout, showing the Payout Ratio.BAM.CA Dividend Payout.PayoutRetained Earnings

BAM.CA Fundamentals: All Metrics, Ratios and Statistics

BROOKFIELD ASSET MGMT-A

TSX:BAM (3/6/2026, 7:00:00 PM)

62.58

-1.98 (-3.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)05-04
Inst Owners17.03%
Inst Owner ChangeN/A
Ins Owners2.31%
Ins Owner ChangeN/A
Market Cap102.50B
Revenue(TTM)4.74B
Net Income(TTM)2.11B
Analysts70.91
Price Target85.13 (36.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP107.77%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.6%
Min EPS beat(2)0.46%
Max EPS beat(2)6.73%
EPS beat(4)3
Avg EPS beat(4)1.88%
Min EPS beat(4)-1.13%
Max EPS beat(4)6.73%
EPS beat(8)5
Avg EPS beat(8)1.58%
EPS beat(12)8
Avg EPS beat(12)2.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.21%
Min Revenue beat(2)-0.85%
Max Revenue beat(2)3.27%
Revenue beat(4)1
Avg Revenue beat(4)-8.1%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)3.27%
Revenue beat(8)1
Avg Revenue beat(8)-4.53%
Revenue beat(12)2
Avg Revenue beat(12)-6.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.76%
PT rev (3m)-7.45%
EPS NQ rev (1m)1.42%
EPS NQ rev (3m)5.58%
EPS NY rev (1m)0.43%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)0.55%
Revenue NQ rev (3m)4.09%
Revenue NY rev (1m)2.52%
Revenue NY rev (3m)2.84%
Valuation
Industry RankSector Rank
PE 26.97
Fwd PE 24.67
P/S 21.7
P/FCF 48.92
P/OCF 48.63
P/B 7.51
P/tB 7.51
EV/EBITDA N/A
EPS(TTM)2.32
EY3.71%
EPS(NY)2.54
Fwd EY4.05%
FCF(TTM)1.28
FCFY2.04%
OCF(TTM)1.29
OCFY2.06%
SpS2.88
BVpS8.34
TBVpS8.34
PEG (NY)2.83
PEG (5Y)3.01
Graham Number20.86
Profitability
Industry RankSector Rank
ROA 12.78%
ROE 21.06%
ROCE 13.91%
ROIC 10.7%
ROICexc 11.58%
ROICexgc 12.13%
OM 52.67%
PM (TTM) 60.89%
GM N/A
FCFM 44.36%
ROA(3y)13.66%
ROA(5y)9.77%
ROE(3y)20.83%
ROE(5y)16.44%
ROIC(3y)6.82%
ROIC(5y)5.8%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.83%
ROCE(5y)7.44%
ROICexgc growth 3YN/A
ROICexgc growth 5Y19.59%
ROICexc growth 3YN/A
ROICexc growth 5Y20.1%
OM growth 3Y177.57%
OM growth 5Y-1.81%
PM growth 3Y0.15%
PM growth 5Y22.8%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.82
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.26%
Interest Coverage 22.83
Cash Conversion N/A
Profit Quality 72.86%
Current Ratio 1.43
Quick Ratio 1.43
Altman-Z 7.79
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.24%
EPS 3Y212.1%
EPS 5Y8.95%
EPS Q2Q%17.5%
EPS Next Y9.52%
EPS Next 2Y13.19%
EPS Next 3Y15.89%
EPS Next 5Y14.22%
Revenue 1Y (TTM)883.61%
Revenue growth 3Y406.83%
Revenue growth 5Y17.46%
Sales Q2Q%42.24%
Revenue Next Year15.52%
Revenue Next 2Y15.48%
Revenue Next 3Y13.51%
Revenue Next 5Y13.18%
EBIT growth 1Y2585.29%
EBIT growth 3Y1306.77%
EBIT growth 5Y15.34%
EBIT Next Year25.37%
EBIT Next 3Y18.62%
EBIT Next 5Y17.15%
FCF growth 1Y177.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y160.44%
OCF growth 3YN/A
OCF growth 5YN/A

BROOKFIELD ASSET MGMT-A / BAM.CA FAQ

Can you provide the ChartMill fundamental rating for BROOKFIELD ASSET MGMT-A?

ChartMill assigns a fundamental rating of 6 / 10 to BAM.CA.


What is the valuation status for BAM stock?

ChartMill assigns a valuation rating of 3 / 10 to BROOKFIELD ASSET MGMT-A (BAM.CA). This can be considered as Overvalued.


Can you provide the profitability details for BROOKFIELD ASSET MGMT-A?

BROOKFIELD ASSET MGMT-A (BAM.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BROOKFIELD ASSET MGMT-A (BAM.CA) stock?

The Price/Earnings (PE) ratio for BROOKFIELD ASSET MGMT-A (BAM.CA) is 26.97 and the Price/Book (PB) ratio is 7.51.


Can you provide the financial health for BAM stock?

The financial health rating of BROOKFIELD ASSET MGMT-A (BAM.CA) is 6 / 10.